Biomarkers of the underlying causes of mild cognitive impairment (MCI) are valuable. But according to a study by the European Alzheimer Disease Centers (EADC) group, guidance on patient counseling is lacking.
Biomarkers of the underlying causes of mild cognitive impairment (MCI) are valuable. But according to a study by the European Alzheimer Disease Centers (EADC) group, guidance on patient counseling is lacking.